Current Opinion in Oncology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of psychiatry is divided into 15 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Dr Marc Sanson, MD, PhD is Professor at Sorbonne Université, Paris, France. He is active in clinical neuro-oncology at the Department of Neurology 2, Pitié-Salpêtrière Hospital in Paris. He is also head of the research team ‘experimental neuro-oncology’ at the Institut du Cerveau et de la Moelle (ICM) in Paris. Dr Sanson is the Director of the recently created “CURAMUS” site of Sorbonne-Université which is one of the eight French Sites for Integrated Research on Cancer (SiRIC).
Dr Sanson has published many research articles on neuro-oncology, including more than 200 dedicated to gliomas, as well as book chapters, and is a frequently requested lecturer on this topic. His main interest is focused on clinical and translational research on gliomas, including novel targeted therapies, germline and somatic genetic characterisation and development of new biomarkers.
He is a reviewer on a number of journals, including the Journal of Clinical Oncology, Lancet, Lancet Oncology, Annals of Oncology, Annals of Neurology, Neurology, Cancer, Clinical Cancer Research, Cancer Research and Acta Neuropathologica.
Dr Sanson earned his MD at University R Descartes and his PhD at University D Diderot, both in Paris. He completed a residency in Neurology in Paris, and a post-doctoral stage at McGill University, Canada.
Miguel A. Sanz
Dr Miguel A. Sanz is Head at the Department of Oncology, Hematology and Bone Marrow Transplant Unit at the University Hospital La Fe in Valencia, Spain, as well as Professor of Medicine at the University of Valencia. After earning his medical degree at the University of Salamanca in Spain, he was intern, resident and subsequently completed a fellowship in Hematology at the University Hospital La Fe.
He was appointed as Head of the Clinical Hematology Section to the University Hospital La Fe in 1977 and then later promoted to Head of the Hematology Department in 2007.
Professor Sanz is Chairman of the Spanish PETHEMA Group and leads the Working Parties of Acute Promyelocytic Leukemia and Infections in Neutropenic Patients. He is currently a reviewer for numerous high-profile medical journals, including all top hematology journals, and has authored more than 540 papers, peer-reviewed papers, numerous book chapters, and over 1100 abstracts at national and international meetings. Prof. Sanz has lectured widely in Europe, North, central and South America, as well as in the Middle East and Asia, and also at the American Society of Hematology and European Hematology Association meetings on several occasions.